Navigation Links
Sigma-Tau Receives Innovation Award From The National Organization for Rare Disorders for Its Advancements in Rare Diseases
Date:5/15/2013

GAITHERSBURG, Md., May 15, 2013 /PRNewswire/ -- Sigma-Tau Pharmaceuticals, Inc. announced today that the Company was recognized last evening as a rare disease pioneer at the 30th anniversary celebration of The National Organization for Rare Disorders (NORD).  During the event, Sigma-Tau received an innovation award for the development of CYSTARAN™ (cysteamine ophthalmic solution) 0.44% --  the first and only approved therapy for the treatment of corneal cystine crystal accumulation in patients with cystinosis.

"NORD applauds Sigma-Tau Pharmaceuticals, NIH researchers, and patient organizations for collaborating to develop CYSTARAN for the treatment of this debilitating eye complication of cystinosis," said Peter L. Saltonstall , President and Chief Executive Officer of NORD. "As one of the first companies to receive an orphan-drug designation nearly 30 years ago, Sigma-Tau is once again demonstrating its strong and enduring commitment to serving rare disease communities with innovative products and effective patient programs."

Sigma-Tau developed CYSTARAN in partnership with the National Institutes of Health (NIH) and in cooperation with the Cystinosis Foundation, the Cystinosis Research Foundation, and the Cystinosis Research Network. The U.S. Food and Drug Administration (FDA) approved CYSTARAN for the treatment of this painful and debilitating eye condition in October 2012.

"We applaud NORD and all award recipients for their dedication to bringing innovative therapies and new hope to patients with rare diseases," said Dave Lemus , Chief Executive Officer of Sigma-Tau. "We are privileged to receive this award and remain committed to serving the rare disease community by developing and delivering innovative therapies."

Patient assistance programs for CYSTARAN are available, including co-pay assistance for eligible pa
'/>"/>

SOURCE Sigma-Tau Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sigma-taus Antimalarial Awarded "Project of the Year" 2011 by Medicines for Malaria Venture
2. Stryker Receives Top Supplier Awards From Novation
3. CitiusTechs BI-Clinical Platform for Healthcare BI & Analytics Receives NCQA HEDIS Certification
4. Source One Management Services Receives SDCE 100 Award for 2013 Source One Wins Supply Chain Excellence for Eighth Consecutive Year
5. Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application
6. China Jo-Jo Drugstores, Inc. Receives Delisting Notice from NASDAQ
7. Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories
8. Hill-Rom Receives FDA 510(k) Clearance to Market MetaNeb 4.0 Airway Clearance System
9. Fully Automated Diagnostic Device Receives CE Certification; IDx LLC Planning For Rollout Across Europe
10. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
11. STD Med, Inc. Receives Second Brazil GP Approval And Adds Med-Tech Regulatory Consulting Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... Fla. , March 3, 2015 ... pleased to announce the hiring of Brian ... to lead business development efforts and build relationships ... of experience in software development, sales, and sales ... enterprise software applications. iTraycer is a comprehensive inventory ...
(Date:3/3/2015)... Pharmaceuticals Inc. (NASDAQ: CPIX ), a ... and gastroenterology, today announced fourth quarter and annual ... in 2014 to $37 million, resulting in Adjusted ... share. At the end of 2014, Cumberland had ... million in cash and investments, with no debt. ...
(Date:3/3/2015)... -- This industry report package offers the most up-to-date market data on the ... world and in the top 10 global countries. Along with a global ... countries: Australia , China ... Italy , Japan , Russia ... , United States The reports include ...
Breaking Medicine Technology:Medical Tracking Solutions, Inc. Hires New SVP, Sales 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 2Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 3Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 4Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 5Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 6Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 7Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 8Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 9Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 10Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 11Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 12Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 13Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 14Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 15Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 16Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 17Cumberland Pharmaceuticals Announces Return To Growth And Profitability In 2014 18Global Safety Glass Market to 2019 - Market Size, Top 10 Countries, Trends, and Forecasts 2
... , , SAN DIEGO, Aug. 27 ... that a recent medical journal article highlights the challenges facing healthcare ... wounds. , , (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ) ... the American Academy of Physician Assistants, (JAAPA, August 2009), chronic wounds ...
... , , MINNEAPOLIS, Aug. 27 ... and marketer of state-of-the-art cardiac surgery products and services, announced ... in which cardiac surgeons will implant the ATS 3f(R) Aortic ... has not been previously studied in a controlled and scientific ...
Cached Medicine Technology:Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 2Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 3Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 4Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 5Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 6Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 7Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 8Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 9Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 10Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers 11ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 2ATS Medical Announces FDA Approval for a Landmark Clinical Investigation of the ATS 3f Aortic Bioprosthesis 3
(Date:3/4/2015)... Information Innovators Inc . (Triple-i) is honored ... the company as Chief Technology Officer. Mr. Dvorak will ... company, including customer-centric strategies and initiatives, and promoting continuous ... as a technology executive and visionary. Prior to joining ... including oversight of enterprise data management, analytic software development, ...
(Date:3/4/2015)... 2015 The Alliance for Regenerative ... its upcoming fifth annual Advanced Therapies Summit next ... event this year will feature five expert-led interactive ... the field’s leading companies and organizations. , ... and clinical researchers from the advanced therapies community ...
(Date:3/4/2015)... March 04, 2015 The Conrad N. ... a total of $6.9 million, which will help 151,000 ... and Burkina Faso. , The programs cover three years ... will focus on fixing water points in disrepair, addressing ... local people to maintain water points and ensuring safe ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Nike Swim ... and staff whose mission is to stimulate a love ... “Nike Swim Camps provide campers the opportunity to train ... nation,” says Paul Merrion, Vice President of US Sports ... enabling each swimmer to build confidence and improve their ...
(Date:3/4/2015)... Nitrosigine®, a patented complex of bonded arginine ... products, is hosting the Nitrosigine Pump Challenge at the ... at The Arnold Sports Festival in Columbus, Ohio. The ... 8, 2015. , Nitrosigine is a patented ingredient ... notification status; now affirmed as GRAS.^ It has been ...
Breaking Medicine News(10 mins):Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 2Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 3Health News:Hilton Foundation Gives $6.9 Million to Sustainable Water Programs in West Africa 4Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3
... and Accelerates Physician TrainingGREAT BARRINGTON, Mass., March 17 ... surgical training models, is improving how ENT physicians ... Trainer. This innovative technology was recently designed ... on their new FinESS(TM) Sinus Treatment, a less-invasive ...
... 17 Innophos Holdings, Inc. (Nasdaq: ... declared a dividend of $0.17 per share of common stock. ... stockholders of record as of the close of business on ... , Innophos Holdings, Inc., the parent company of Innophos, Inc. ...
... the past few years, a number of anti-cancer drugs ... key molecules of tumor cells. Among these is an ... that is found in large amounts on the surface ... molecule, called epidermal growth factor receptor, or EGF-R for ...
... for Drug Evaluation and Research (CDER), industry, and academia will convene ... (April 26-29; Arlington, VA) to discuss statistical methodologies and quantitative ... , ... Horsham, PA (Vocus) March 17, 2009 -- ...
... John Hancock Life Insurance Company led the industry ... to recent industry year-end surveys of LTC insurers.* In ... across all of its LTC insurance businesses, giving the ... marks John Hancock,s second year in a row as ...
... What can you buy with a dollar anymore? ... and treatment for those who cannot afford to battle breast ... Brandon Mendelson and the 1 in 8 Foundation are challenging ... $1 and provide care and complete support for women and ...
Cached Medicine News:Health News:Chamberlain Group Surgical Training Model Facilitates New Treatment for Chronic Rhinosinusitis 2Health News:Chamberlain Group Surgical Training Model Facilitates New Treatment for Chronic Rhinosinusitis 3Health News:Innophos Holdings, Inc. Declares Quarterly Dividend 2Health News:Lung cancer: Molecular scissors determine therapy effectiveness 2Health News:Drug Information Association (DIA)and Food and Drug Administration (FDA) to Host 3rd Annual Statistics Forum 2Health News:John Hancock #1 in Long-Term Care Insurance Industry Sales in 2008 2Health News:John Hancock #1 in Long-Term Care Insurance Industry Sales in 2008 3Health News:$1 Can Make The Difference 2
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
... VACUETTE Blood Collection Needles are preominantly used ... for single-use. The colour of the needle ... individual needle gauges. For example, yellow symbolises ... green 21 G (0.80 mm) and black ...
ScanGel® Centrifuge...
BIOVUE cassettes may be used manually, with a workstation consisting of a centrifuge, incubator, precision pipettes and work rack....
Medicine Products: